Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Titan Medical Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.055 |
52 Week High | CA$0.23 |
52 Week Low | CA$0.05 |
Beta | 2 |
11 Month Change | 0% |
3 Month Change | -21.43% |
1 Year Change | -65.63% |
33 Year Change | -97.41% |
5 Year Change | -98.08% |
Change since IPO | -99.67% |
Recent News & Updates
Revenues Working Against Titan Medical Inc.'s (TSE:TMD) Share Price
Jan 09There's No Escaping Titan Medical Inc.'s (TSE:TMD) Muted Revenues
Sep 25Shareholder Returns
TMD | CA Medical Equipment | CA Market | |
---|---|---|---|
7D | 10.0% | -2.2% | 1.2% |
1Y | -65.6% | -31.6% | 11.8% |
Return vs Industry: TMD underperformed the Canadian Medical Equipment industry which returned -31.6% over the past year.
Return vs Market: TMD underperformed the Canadian Market which returned 11.8% over the past year.
Price Volatility
TMD volatility | |
---|---|
TMD Average Weekly Movement | 15.0% |
Medical Equipment Industry Average Movement | 9.2% |
Market Average Movement | 8.0% |
10% most volatile stocks in CA Market | 16.8% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: TMD's share price has been volatile over the past 3 months.
Volatility Over Time: TMD's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 4 | Paul Cataford | www.titanmedicalinc.com |
Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.
Titan Medical Inc. Fundamentals Summary
TMD fundamental statistics | |
---|---|
Market cap | CA$5.70m |
Earnings (TTM) | CA$11.88m |
Revenue (TTM) | CA$24.03m |
0.5x
P/E Ratio0.3x
P/S RatioIs TMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TMD income statement (TTM) | |
---|---|
Revenue | US$17.63m |
Cost of Revenue | US$0 |
Gross Profit | US$17.63m |
Other Expenses | US$8.92m |
Earnings | US$8.72m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.076 |
Gross Margin | 100.00% |
Net Profit Margin | 49.44% |
Debt/Equity Ratio | 0% |
How did TMD perform over the long term?
See historical performance and comparison